Back to Search Start Over

What Constitutes a Valid Surrogate End Point in Cancer Clinical Trials?

Authors :
Shyr Y
Shyr D
Source :
JAMA oncology [JAMA Oncol] 2020 Sep 01; Vol. 6 (9), pp. 1334-1335.
Publication Year :
2020

Subjects

Subjects :
Biomarkers
Follow-Up Studies
Humans
Breast Neoplasms
Neoadjuvant Therapy

Details

Language :
English
ISSN :
2374-2445
Volume :
6
Issue :
9
Database :
MEDLINE
Journal :
JAMA oncology
Publication Type :
Editorial & Opinion
Accession number :
32701117
Full Text :
https://doi.org/10.1001/jamaoncol.2020.1847
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details